• Login
    View Item 
    •   BEARdocs Home
    • Graduate School
    • Electronic Theses and Dissertations
    • View Item
    •   BEARdocs Home
    • Graduate School
    • Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Anti-tumor properties of CD40 ligand when delivered as a transgene by the conditional replicative oncolytic adenovirus AdEH to breast cancer cells.

    Thumbnail
    View/Open
    Dissertation (2.076Mb)
    Permission Form (122.1Kb)
    Access rights
    Worldwide access.
    Access changed 5/25/11.
    Date
    2007-02-14
    Author
    Gomes, Erica Manuela.
    Metadata
    Show full item record
    Abstract
    Cancer-selective biotherapy and gene therapy have been considered to be the next horizon towards developing a cure for breast cancer. CD40 ligand (CD40L), a member of the tumor necrosis factor superfamily, relays critical growth signals in various hematological malignancies and carcinomas. We previously demonstrated that recombinant CD40L can directly inhibit breast cancer cell growth. However a potential limitation of CD40L therapy is systemic toxicity. To improve efficacy of gene delivery and limit CD40L expression to the tumor micro-environment, we have generated a conditionally replicative virus (AdEHCD40L) that delivers CD40L selectively to breast carcinomas. Tumor/tissue-specific promoters (hypoxic/HIF-1α response and estrogen response elements) were incorporated to limit CD40L expression to the tumor microenvironment. Viral E1A and CD40L transgene expression was examined in breast cancer lines with low constitutive (T47D) or no (BT-20) HIF-1α expression. Both cell lines displayed significantly increased CD40L expression under viral- permissive conditions (T47D: 65.5 ± 3.9% with increased HIF-1α vs. 38.5 ± 2.8% under uninduced condition, p = 0.01; BT20: 43.2 ± 14.9% vs. 10.6 ± 0.2%, p = 0.03). AdEHCD40L produced markedly stronger inhibition compared to the parental construct (T47D: 53.7 ± 15.2% vs. 32.1 ± 11.7%, p = 0.02; BT20: 25.8 ± 10.2% vs. 15.2 ± 6.8%, p = 0.03), suggesting that growth inhibition encompassed CD40L-mediated and viral oncolytic events. Replicative activity of AdEHCD40L was comparable to the wild type adenovirus in breast cancer cells and attenuated in normal lung fibroblast cells, with reduced growth inhibitory impact. Preliminary findings on mechanisms of AdEHCD40L cytotoxicity indicated increased apoptotic (Annexin V+) and necrotic (propidium iodide incorporation) activities that were accompanied by reduced IBα, phosphorylation, G2M/S cell cycle arrest, culminating in an increased sub-G0 fraction, and altered chemokine/cytokine expression. AdEHCD40L biodistribution and its maximum tolerated dose (2x108 pfu) evaluated in mice were comparable to that of other conditional-replicative adenoviruses. Anti-tumor efficacy of AdEHCD40L showed a reduction in mean tumor diameter of MDA-MB-231 (44-58%) and T47D (49%) human breast cancer xenografts in SCID mice. These findings illustrate the applicability of CD40L gene transfer approach for experimental treatment of human breast cancer.
    URI
    http://hdl.handle.net/2104/4901
    Department
    Biomedical Studies.
    Collections
    • Electronic Theses and Dissertations
    • Theses/Dissertations - Biology

    Copyright © Baylor® University All rights reserved. Legal Disclosures.
    Baylor University Waco, Texas 76798 1-800-BAYLOR-U
    Baylor University Libraries | One Bear Place #97148 | Waco, TX 76798-7148 | 254.710.2112 | Contact: libraryquestions@baylor.edu
    If you find any errors in content, please contact librarywebmaster@baylor.edu
    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    TDL
    Theme by 
    Atmire NV
     

     

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    Statistics

    View Usage Statistics

    Copyright © Baylor® University All rights reserved. Legal Disclosures.
    Baylor University Waco, Texas 76798 1-800-BAYLOR-U
    Baylor University Libraries | One Bear Place #97148 | Waco, TX 76798-7148 | 254.710.2112 | Contact: libraryquestions@baylor.edu
    If you find any errors in content, please contact librarywebmaster@baylor.edu
    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    TDL
    Theme by 
    Atmire NV